This isn’t science fiction. It’s emerging biology — and it might be the key to slowing, or even halting, the aging process.

NTR-1011 demonstrated a favorable safety, tolerability, and immunogenicity profile across multiple dose levels of intravenous (IV) and ...

A study by researchers at the University of California San Diego could make it easier to treat breast cancer by uncovering a ...

A study by researchers at the University of California San Diego could make it easier to treat breast cancer by uncovering a ...

Researchers used sophisticated molecular tagging systems in mouse models of brain, lung, and pancreatic cancer to directly ...

Biohaven’s first-in-modality extracellular degrader BHV-1300 reduced levels of its immunoglobulin G (IgG) target by up to 43% in an ongoing phase I trial. The two-armed small molecule acts by dragging ...

A novel vaccine platform has been developed to induce broad, protective immunity against numerous influenza virus infections, ...

Landmark Bio, an Artis BioSolutions company dedicated to accelerating the translation of next-generation advanced therapies from discovery to clinical and commercial production, today announced that ...

Explore the role of extracellular RNA in bacteria, communication, and its implications for medicine and disinfectant development.